GARIAZZO, ELEONORA
GARIAZZO, ELEONORA
A Podcast on Pre- or Perioperative Chemoimmunotherapy for Stage III Non-Small Cell Lung Cancer: Shared Agreement from the Thoracic Surgeon and Oncologist Perspectives
2024 Bertolaccini, Luca; De Giglio, Andrea; Gariazzo, Eleonora; Metro, Giulio
A prospective study on clinicians' attitudes and survival outcomes for patients with advanced NSCLC and poor performance status in the immunotherapy era: PICASO (GOIRC-04-2020)
2025 Facchinetti, Francesco; Camerini, Andrea; Bennati, Chiara; Bordi, Paola; Carlo, Elisa De; Mazzoni, Francesca; Metro, Giulio; Bertolini, Federica; Longo, Lucia; Ricciardi, Serena; Pilotto, Sara; Giardina, Donatella; Passiglia, Francesco; Scotti, Vieri; Piacentini, Paolo; Frega, Stefano; Calabrò, Luana; Guida, Annalisa; Grosso, Maria Antonietta; Longobardi, Jenny; Merlini, Alessandra; Cosso, Federica; Leonetti, Alessandro; Gariazzo, Eleonora; Guaitoli, Giorgia; Belluomini, Lorenzo; Bearz, Alessandra; Tognetto, Michele; Bria, Emilio; Cortinovis, Diego Luigi; Novello, Silvia; Maio, Massimo Di; Tiseo, Marcello
Correction: Repotrectinib’s Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer (Oncology and Therapy, (2024), 12, 1, (163-171), 10.1007/s40487-023-00251-6)
2024 Metro, G.; Gariazzo, E.; Costabile, S.; Baglivo, S.; Roila, F.; Colamartini, F.; Palumbo, B.; Chiarini, P.; Gori, S.; Conti, A.; Marcomigni, L.; Bellezza, G.; Lunardi, G.
Navigating challenges in EGFR exon 20 insertions: The PAPILLON trial unravels the promise of amivantamab-chemotherapy
2024 De Giglio, Andrea; Di Federico, Alessandro; Gariazzo, Eleonora; Metro, Giulio
Non-small cell lung cancer: an update on emerging EGFR-targeted therapies
2024 Favorito, Valentina; Ricciotti, Ilaria; De Giglio, Andrea; Fabbri, Laura; Seminerio, Renata; Di Federico, Alessandro; Gariazzo, Eleonora; Costabile, Silvia; Metro, Giulio
Repotrectinib’s Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer
2023 Metro, G.; Gariazzo, E.; Costabile, S.; Baglivo, S.; Roila, F.; Colamartini, F.; Palumbo, B.; Chiarini, P.; Gori, S.; Conti, A.; Marcomigni, L.; Bellezza, G.; Lunardi, G.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A Podcast on Pre- or Perioperative Chemoimmunotherapy for Stage III Non-Small Cell Lung Cancer: Shared Agreement from the Thoracic Surgeon and Oncologist Perspectives | 2024 | Bertolaccini, Luca; De Giglio, Andrea; Gariazzo, Eleonora; Metro, Giulio | |
| A prospective study on clinicians' attitudes and survival outcomes for patients with advanced NSCLC and poor performance status in the immunotherapy era: PICASO (GOIRC-04-2020) | 2025 | Facchinetti, Francesco; Camerini, Andrea; Bennati, Chiara; Bordi, Paola; Carlo, Elisa De; Mazzoni, Francesca; Metro, Giulio; Bertolini, Federica; Longo, Lucia; Ricciardi, Serena; Pilotto, Sara; Giardina, Donatella; Passiglia, Francesco; Scotti, Vieri; Piacentini, Paolo; Frega, Stefano; Calabrò, Luana; Guida, Annalisa; Grosso, Maria Antonietta; Longobardi, Jenny; Merlini, Alessandra; Cosso, Federica; Leonetti, Alessandro; Gariazzo, Eleonora; Guaitoli, Giorgia; Belluomini, Lorenzo; Bearz, Alessandra; Tognetto, Michele; Bria, Emilio; Cortinovis, Diego Luigi; Novello, Silvia; Maio, Massimo Di; Tiseo, Marcello | |
| Correction: Repotrectinib’s Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer (Oncology and Therapy, (2024), 12, 1, (163-171), 10.1007/s40487-023-00251-6) | 2024 | Metro, G.; Gariazzo, E.; Costabile, S.; Baglivo, S.; Roila, F.; Colamartini, F.; Palumbo, B.; Chiarini, P.; Gori, S.; Conti, A.; Marcomigni, L.; Bellezza, G.; Lunardi, G. | |
| Navigating challenges in EGFR exon 20 insertions: The PAPILLON trial unravels the promise of amivantamab-chemotherapy | 2024 | De Giglio, Andrea; Di Federico, Alessandro; Gariazzo, Eleonora; Metro, Giulio | |
| Non-small cell lung cancer: an update on emerging EGFR-targeted therapies | 2024 | Favorito, Valentina; Ricciotti, Ilaria; De Giglio, Andrea; Fabbri, Laura; Seminerio, Renata; Di Federico, Alessandro; Gariazzo, Eleonora; Costabile, Silvia; Metro, Giulio | |
| Repotrectinib’s Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer | 2023 | Metro, G.; Gariazzo, E.; Costabile, S.; Baglivo, S.; Roila, F.; Colamartini, F.; Palumbo, B.; Chiarini, P.; Gori, S.; Conti, A.; Marcomigni, L.; Bellezza, G.; Lunardi, G. |